BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 12842009)

  • 1. Rnd proteins function as RhoA antagonists by activating p190 RhoGAP.
    Wennerberg K; Forget MA; Ellerbroek SM; Arthur WT; Burridge K; Settleman J; Der CJ; Hansen SH
    Curr Biol; 2003 Jul; 13(13):1106-15. PubMed ID: 12842009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rnd1 and Rnd3 targeting to lipid raft is required for p190 RhoGAP activation.
    Oinuma I; Kawada K; Tsukagoshi K; Negishi M
    Mol Biol Cell; 2012 Apr; 23(8):1593-604. PubMed ID: 22357615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GTPase-deficient Rnd proteins are stabilized by their effectors.
    Goh LL; Manser E
    J Biol Chem; 2012 Sep; 287(37):31311-20. PubMed ID: 22807448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, Bcr, and 3BP-1.
    Zhang B; Zheng Y
    Biochemistry; 1998 Apr; 37(15):5249-57. PubMed ID: 9548756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RhoA GEF Syx is a target of Rnd3 and regulated via a Raf1-like ubiquitin-related domain.
    Goh LL; Manser E
    PLoS One; 2010 Aug; 5(8):e12409. PubMed ID: 20811643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway.
    Kontaridis MI; Eminaga S; Fornaro M; Zito CI; Sordella R; Settleman J; Bennett AM
    Mol Cell Biol; 2004 Jun; 24(12):5340-52. PubMed ID: 15169898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The function of the p190 Rho GTPase-activating protein is controlled by its N-terminal GTP binding domain.
    Tatsis N; Lannigan DA; Macara IG
    J Biol Chem; 1998 Dec; 273(51):34631-8. PubMed ID: 9852136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
    Wang L; Yang L; Luo Y; Zheng Y
    J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants required for the interaction between Rho GTPase and the GTPase-activating domain of p190.
    Li R; Zhang B; Zheng Y
    J Biol Chem; 1997 Dec; 272(52):32830-5. PubMed ID: 9407060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling.
    Barberis D; Casazza A; Sordella R; Corso S; Artigiani S; Settleman J; Comoglio PM; Tamagnone L
    J Cell Sci; 2005 Oct; 118(Pt 20):4689-700. PubMed ID: 16188938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of Rho GTPases by p190 RhoGAP reduces human pancreatic cancer cell invasion and metastasis.
    Kusama T; Mukai M; Endo H; Ishikawa O; Tatsuta M; Nakamura H; Inoue M
    Cancer Sci; 2006 Sep; 97(9):848-53. PubMed ID: 16776779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rnd3/p190RhoGAP pathway regulates RhoA activity in idiopathic pulmonary fibrosis fibroblasts.
    Monaghan-Benson E; Wittchen ES; Doerschuk CM; Burridge K
    Mol Biol Cell; 2018 Sep; 29(18):2165-2175. PubMed ID: 29995590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pragmin, a novel effector of Rnd2 GTPase, stimulates RhoA activity.
    Tanaka H; Katoh H; Negishi M
    J Biol Chem; 2006 Apr; 281(15):10355-64. PubMed ID: 16481321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating axon branch stability: the role of p190 RhoGAP in repressing a retraction signaling pathway.
    Billuart P; Winter CG; Maresh A; Zhao X; Luo L
    Cell; 2001 Oct; 107(2):195-207. PubMed ID: 11672527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-kinase contributes to sustained RhoA activation through phosphorylation of p190A RhoGAP.
    Mori K; Amano M; Takefuji M; Kato K; Morita Y; Nishioka T; Matsuura Y; Murohara T; Kaibuchi K
    J Biol Chem; 2009 Feb; 284(8):5067-76. PubMed ID: 19103606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity.
    Chen JC; Zhuang S; Nguyen TH; Boss GR; Pilz RB
    J Biol Chem; 2003 Jan; 278(5):2807-18. PubMed ID: 12429740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of RhoGAP activity is sufficient for the induction of Rho-mediated actin reorganization.
    Vincent S; Settleman J
    Eur J Cell Biol; 1999 Aug; 78(8):539-48. PubMed ID: 10494860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rho family GTPase activating proteins p190, bcr and rhoGAP show distinct specificities in vitro and in vivo.
    Ridley AJ; Self AJ; Kasmi F; Paterson HF; Hall A; Marshall CJ; Ellis C
    EMBO J; 1993 Dec; 12(13):5151-60. PubMed ID: 8262058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of p190 Rho-GAP by v-Src is linked to cytoskeletal disruption during transformation.
    Fincham VJ; Chudleigh A; Frame MC
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():947-56. PubMed ID: 10036244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GTPase and Rho GAP domains of p190, a tumor suppressor protein that binds the M(r) 120,000 Ras GAP, independently function as anti-Ras tumor suppressors.
    Wang DZ; Nur-E-Kamal MS; Tikoo A; Montague W; Maruta H
    Cancer Res; 1997 Jun; 57(12):2478-84. PubMed ID: 9192829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.